Syncromune Inc
Syncromune Inc., based in Fort Lauderdale, FL, is at the forefront of developing innovative combination immunotherapies aimed at enhancing the immune system's ability to recognize and combat cancer. Their flagship platform, SYNC-T, is a personalized in situ therapy that employs a unique approach of combining localized tumor breakdown with the infusion of a multi-target biologic drug directly into the tumor.
This pioneering method seeks to tackle various immune suppression mechanisms while simultaneously stimulating the immune response, thereby educating the body's defenses to target cancer more effectively. With ongoing clinical trials and a commitment to advancing cancer treatment, Syncromune is poised to make significant contributions to the field of immunotherapy.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

